RAVAROTTO, VERDIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.278
AS - Asia 323
EU - Europa 277
OC - Oceania 3
AF - Africa 2
Totale 2.883
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.276
CN - Cina 182
SG - Singapore 110
IT - Italia 94
SE - Svezia 42
FI - Finlandia 28
DE - Germania 25
FR - Francia 23
GB - Regno Unito 14
SI - Slovenia 14
VN - Vietnam 14
IN - India 11
NL - Olanda 11
UA - Ucraina 7
CH - Svizzera 5
MK - Macedonia 4
AT - Austria 3
IE - Irlanda 3
BG - Bulgaria 2
CA - Canada 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
PH - Filippine 2
UG - Uganda 2
AU - Australia 1
BE - Belgio 1
ID - Indonesia 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 2.883
Salva come PNG Salva come JPEG
Città #
Fairfield 433
Chandler 316
Ashburn 195
Woodbridge 186
Cambridge 145
Seattle 135
Wilmington 116
Houston 115
Ann Arbor 92
Singapore 86
Santa Clara 59
Boardman 58
Beijing 46
Padova 40
San Diego 37
Medford 34
Princeton 34
Des Moines 31
Helsinki 24
Nanjing 19
New York 19
Dong Ket 14
Roxbury 14
Jinan 10
Nanchang 8
Hefei 7
Shanghai 7
Cagliari 6
Falls Church 6
Amsterdam 5
Guangzhou 5
Kunming 5
Hebei 4
Kilburn 4
Redwood City 4
Rome 4
Changsha 3
Dublin 3
Fuzhou 3
Hangzhou 3
Lanzhou 3
Las Vegas 3
Lausanne 3
Los Angeles 3
Naples 3
Norwalk 3
Phoenix 3
Washington 3
Bitola 2
Chongqing 2
Dallas 2
Edinburgh 2
Esslingen am Neckar 2
Hong Kong 2
Jiaxing 2
Kampala 2
Kharkiv 2
Lappeenranta 2
London 2
Milan 2
Ningbo 2
Ogden 2
Palo Alto 2
Paris 2
Prilep 2
Pune 2
San Jose 2
Selvazzano Dentro 2
Sofia 2
Taizhou 2
Vienna 2
Voghera 2
Zhengzhou 2
Zurich 2
Atlanta 1
Avellino 1
Baotou 1
Borås 1
Brussels 1
Carmichael 1
Carol Stream 1
Chengdu 1
Chiswick 1
Christchurch 1
Dearborn 1
Fabriano 1
Frankfurt am Main 1
Gunzenhausen 1
Islington 1
Jakarta 1
Lucca 1
Melbourne 1
Miami 1
Mission 1
Munich 1
Ottawa 1
Prescot 1
Québec 1
Rockville 1
Shenyang 1
Totale 2.437
Salva come PNG Salva come JPEG
Nome #
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway 157
Searching for an additional treatment to slowing the progression of Fabry disease 143
Oxidative stress - chronic kidney disease - cardiovascular disease: A vicious circle 137
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 130
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement? 119
Is heme oxygenase-1 turning out to be a key positive regulator for oxidative stress? 114
Comment on “Vitamin E supplementation improves high-density lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis” by Mune et al. Clinical Nephrology DOI 10.5414/CN109197 e-pub: April 9, 2018 105
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 104
Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications. 103
Bartter's and Gitelman's syndromes 103
Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients. 101
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 97
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 93
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 91
SP021CARDIOVASCULAR-RENAL REMODELING IN FABRY DISEASE: POSSIBLE INVOLVEMENT OF OXIDATIVE STRESS. A MOLECULAR BIOLOGY APPROACH 91
Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism. 81
Gitelman's Syndrome: characterization of a novel c.1181G>A point mutation and functional classification of the known mutations. 80
Molecular Characterization of A Novel Mutation In The Renal NaCl Cotransporter Causing Gitelman'€™s Syndrome By Impairing Transporter Trafficking 79
ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman’s and Bartter’s Syndromes. 78
Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension. 74
Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients 74
The importance of chronic magnesium deficiency in human disease and the Gitelman’s syndrome paradox 73
Oxidative stress in hypertension and cardiovascular-renal remodeling:focus on the renin-angiotensin-aldosterone system 70
ROCK (RhoA/Rho Kinase) in Cardiovascular–Renal Pathophysiology: A Review of New Advancements 69
Could nutritional therapy take us further in our approaches to Fabry disease? 65
The counter-regulatory arm of the renin-angiotensin system and COVID-19: insights from Gitelman's and Bartter's syndromes. 56
Tracing Angiotensin II's Yin -Yang effects on cardiovascular-renal pathophysiology. Yin and yang systems of Ang II. 54
The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease 51
The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman’s and Bartter’s Syndromes 44
Effects of Tolvaptan on Oxidative Stress in ADPKD: A Molecular Biological Approach 44
Rho kinase activity and atrial fibrillation: insights fromchronic kidney disease and dialysis patients. 40
Reduced oxidative stress in ADPKD patients treated with tolvaptan. 35
Rho kinase inhibition: from hypertension to cardiovascular-renal remodeling and more. 34
The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study 33
Relationship between NOX4 level and angiotensin II signaling in Gitelman's syndrome. Implications with hypertension. 31
Molecular aspects of the altered Angiotensin II signaling in Gitelman’s syndrome 26
Pathomechanism of oxidative stress in cardiovascularrenal remodeling and therapeutic strategies. 25
Gitelman’s and Bartter’s syndromes: from genetics to the molecular basis of hypertension and more. 20
Totale 2.924
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.775
article - articoli 11.398
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 619
Totale 24.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020367 0 0 0 0 0 0 93 73 88 43 55 15
2020/2021358 24 20 22 20 10 13 31 30 48 42 30 68
2021/2022480 22 44 34 32 24 52 30 38 30 20 34 120
2022/2023537 87 68 40 78 79 62 2 35 55 0 26 5
2023/2024276 12 25 23 22 26 54 37 15 14 11 19 18
2024/2025268 7 54 32 45 96 34 0 0 0 0 0 0
Totale 2.924